Dataset Information
Response of renal cell carcinoma to ibrutinib, a bruton tyrosine kinase inhibitor, in a patient treated for chronic lymphocytic leukemia.
Ontology highlight
ABSTRACT:
SUBMITTER: Hosier GW
PROVIDER: S-EPMC5426947 | biostudies-literature | 2017 May
REPOSITORIES: biostudies-literature